TRANSCRIPT

Q3 2025 — Results management remarks

Q3 2025PDF · 23 pages274 KB
Investor Relations
1
Barclays PLC Q325 Results
Results call Q&A transcript (amended in places to improve accuracy and readability)
C.S. Venkatakrishnan, Barclays Group Chief Executive
Anna Cross, Barclays Group Financial Director
Guy Stebbings, BNP Exane
Hi, morning Venkat, morning Anna. Thanks for taking the questions. The �rst one was on the US
Consumer [Bank] top line. Clearly very strong up 20% year over year, both non-interest income
and then the NIM moving up to 11.5%. Just helpful to understand if there's anything particularly
lumpy in there.
So, I guess �rstly, just to con�rm that we should be thinking about growth of that 11.5% NIM base,
given the sort of ongoing lending mix actions you've talked to and growth in retail deposit base.
And then within that £215 million of non-interest income in Q3, anything lumpy in there, you
would point to, to temper us away from analysing north of £800 million before thinking about
things like gains on sales or portfolios next year.
And then the second question was just on UK Mortgages. From a volume perspective, very strong
both net and gross lending. Nearly £10 billion in gross lending is certainly above typical run rates.
I'm just interested if that's the level you think you will continue to write at. And then from a sort of
competitive perspective, what you're seeing in the market. I know the actions you're taking, and
Kensington ofers quite a bit of insulation, but are you seeing any competitive pressures on new
lending spreads when you look at like for like lending? Thank you.
Anna Cross
Okay, thanks Guy. I'll take both of those and thanks for opening the call for us. And just on the US
Consumer [Bank] top line, I think what you're seeing coming together now is a real combination
of all of the operational actions that we've been undertaking over the last few quarters. And you
can see that on a new slide on Slide 24.
Because it's drawn from those operational actions, we do have con�dence in its sustainability.
Really what's driving the NIM is the things that we've talked about before. So, it's the repricing,
which remember takes some time to work its way through into the NIM because customers need

-- 1 of 23 --

Investor Relations
2
to draw down on those new terms and conditions. It's also the increase in the level of retail
deposits, and retail deposits are about 50 basis points to 60 basis points cheaper than the other
sources of funding we've had previously. And then thirdly, there is this increasing proportion of
retail balances, which are higher NIM. So I expect over the next couple of quarters, Q4 and Q1 to
be broadly at the level of NIM that we're currently running at, around 11.5%. I'm not going to guide
you to Q2 and beyond, because obviously, once we exit the American Airlines portfolio, that NIM
is going to jump up again. So, I will guide you to that a little nearer the time.
In terms of non-interest income, there's a couple of things going on in there. The �rst is obviously
the increase in volume that we're seeing, not just from General Motors, but also the organic
growth in this business. So, if you go back to the equivalent quarter just before the start of the
plan, we've grown 13% since then.
So, you're seeing that coming through in non-NII and you're also seeing some improvement in
partner sharing agreements, just re�ected in that number. So, we do have con�dence in the
momentum in the income line. I just remind you that this is a seasonal business and you get that
seasonality in NII because of balances, but you also get it in non-interest income. But yes, we're
pleased with that progress.
In UK mortgages, the UK mortgage market is robust, and we see that across the piece. We see it
in house purchase; �rst-time buyers are up 11% year on year. We're seeing strong levels of
re�nancing, and the margins in Barclays, if you like, in the more vanilla book, have been broadly
stable over the last few quarters. Obviously, we're seeing a margin bene�t coming through from
Kensington, which is 3x to 4x higher.
And really what you're seeing here is our capabilities reaching the marketplace. And by that, what
I mean is both the product breadth, because we now got Kensington in play, but also the
operational capabilities because we launched a new broker platform, which is working extremely
well.
The only thing I'd call out for you is we're about to enter a period, market-wide, it's not a Barclays
thing, where we've got coming to maturity the �ve-year business that was written during the
stamp duty holiday in FY20 and FY21. That's at relatively wide margins, so you're going to see a
little bit of churn compression come through on that, but of course, we've captured that in the
guidance that we've already given you around NII progression for BUK.
Thank you, next question please.

-- 2 of 23 --

Investor Relations
3
Jason Napier, UBS
Good morning. Thank you for taking my questions.
The �rst one, just looking at competitive conditions in US Investment Banking, we've had some
of the peers talk about potentially very signi�cant levels of additional capital that's available for
deployment following some of the deregulation and stress test changes. And Prime appears to
be one of the places that they may be looking to allocate additional capacity. So, given it's a focus
for the bank, could you just talk about whether you think you have additional capital to deploy
given the changes in things like stress tests and what you're seeing on product margins and that
sort of thing?
And then secondly, on the non-bank �nancial intermediary (NBFI) space, thank you for the
additional disclosures. Those are really welcome and it's good to see the impairment charge at a
group level below consensus today.
Venkat, I wonder whether you could talk a little bit about risks in that industry, how mature the
exposures are, whether there are any vintages we should be bothered about. We could observe
that the cases we've seen so far all involve fraud, but we have seen very strong growth in the
industry writ large. And so, I wonder with your risk management hat on, whether you could just
talk about, whether this is an industry that has yet to grind into fully mature loss run rates and how
you think about that sort of thing. Thank you.
C.S. Venkatakrishnan
All right. Thank you Jason for both questions. On the first one on capital regulation or disparity,
potential disparity in capital regulation between Europe, the UK and the US. Look, it is, I think, an
important factor in the industry. We haven't seen ultimately what will be the changes in the US
and how much the UK, which is the important jurisdiction for us as a home regulator, makes itself
consistent or not.
I think what I would point out on things like Prime is, we've got a good and strong market share.
We work with a few important and big clients carefully. It is as much a balance sheet business as it
is a capital business. And so, we think we've got the wherewithal, and given our current market
position, given our product capability, given our client penetration, we've got the wherewithal to
compete efectively and continue to compete efectively. Of course, it's all subject to capital rules.
We'll have to see where they are, but I'm pretty confident in the strength of that business and how
we will adapt overall in the Investment Bank, because ultimately, it's about that.

-- 3 of 23 --

Investor Relations
4
Coming back to private credit and NBFI, so here's what I will say. First of all, I view credit as credit
as credit, right? There's a distinction about where it's originated from, and you know, private
credit, generally, we at least think of it as the kind of credit that's originated outside of banks and
outside of the public debt market.
But I think of lending as lending, and through the cycle, you've got to be careful about all the
aspects of lending. Client selection, sector concentrations, NIM concentrations, terms, and
continuous monitoring, qualifying them initially and monitoring it over the time period. So that's
important, and that you've got to do through the period.
I'm obviously disappointed that we had Tricolor. The fact that it was fraud is no excuse. We have
looked at what lessons we can learn from that and apply that across our portfolios. I will talk a little
about that. We did not have First Brands. We were approached a couple of times, and we said no.
We said no because our credit o�cers felt that there was not enough data information to support
the �nancial projections they made. That’s how credit selection is supposed to work.
Now, at this point in time, and you talk a little about vintages. Less to me a question about vintage,
but two questions, one is are there circumstances either because of in�ation, tarifs or changes
in general economic conditions that put stress on credit performance. So, do companies find
themselves stretched?
Now fraud can be isolated bad actors, or it could be economic conditions that increase the
propensity towards bad acting. And then if you worry about that, you've got to consider very
carefully the independence and strength of the financial controls employed within the companies.
Now as you can imagine, we consider all of these things over time. But I think what these two
instances show is that we will likely be monitoring our portfolios more carefully, particularly
understanding the impact of changed economic conditions on companies and looking closely at
the strength and independence of financial controls. Hope that answers your question. Thanks.
Chris Cant, Autonomous
Good morning. Thanks for taking my questions. I just wanted to follow-up on the US Consumer
[Bank] and then another one around sort of risks that investors are worrying about of late.
So, on the US Consumer Bank, we've had this target for a while for the business to get to a greater
than 12% RoTE for next year. I appreciate that quite a few things have changed over the last 18
months to two years since you gave that guidance, in terms of the American Airlines book now
expecting to move of and so on.

-- 4 of 23 --

Investor Relations
5
Given where we've got to with Q3 in terms of the returns, could you give us a bit more colour as
to what return you expect that segment to be delivering in 2026, obviously greater than 12% is
open-ended. That would be helpful, I think, to sort of realign consensus expectations on that
division a little bit.
And then the other topic I wanted to throw out there beyond private credit was stablecoins.
There's been some nervousness over the summer months from some investors around what
threat stablecoin issuance creates for the banking system. I guess more so on the other side of
the pond, given that's where most of these innovations are being deployed first. So, I just wanted
to invite you to comment, Venkat, in terms of how you think that potentially shapes up for the
business longer term. Thank you.
Anna Cross
Thanks, Chris. I'll start on US Consumer Bank and then I'll hand to Venkat. In terms of US
Consumer Bank, it's exactly where we expected it would be, and we continue to target that RoTE
of greater than 12%. Clearly, 2026 statutory RoTE will be impacted by the gain on sale of American
Airlines. It's a bit too early to guide you on that, Chris, we will do nearer the time but think on an
underlying basis that we are aiming to achieve the kind of progress that we set out for you in the
targets that we set.
Beyond 2026, we remain committed to pushing this business further and you can see that with
the momentum that's coming through now, and we'd expect to continue around income, around
operational costs also. So, we've got many levers that we can continue to pull, and we really think
this should be a mid-teens business. Venkat?
C.S. Venkatakrishnan
Yes. Look, stablecoins, it's a broad and fascinating subject, Chris, so thanks for the question. I'll
try to confine my answer, though. There are a couple of dimensions of it. One is, what does it do
to deposits? Second is, how much does it represent an alternative form of payment? And third is,
is it an alternative form of payment on an alternative network?
I think the deposit question for the big banks is something which the banks will have to consider
along with our regulators, because the real question is, is this something that sits outside the
deposit system, or is it brought within the deposit system? And it's a very critical question to
answer, because it relates to the transmission of monetary policy.

-- 5 of 23 --

Investor Relations
6
The second thing is, as a store of value, and the form of deposit that it takes, the initial use cases
seem to be more promising in developing countries, so where people might use it as a dollar
substitute for their local currency. Less clear in case within US or the UK or even Europe.
The third thing is, even if you accepted the first two, is there a separate network upon which this
can travel? I can tell you what Barclays' approach is. We think any of these are possibilities. It's a
very promising and broad-reaching technology. Will it ultimately work? I don't know, but we've got
to investigate it and be part of it.
So, you might have seen announcements that we are part of consortia with other banks, and
obviously no one bank can act alone. We are studying the technology, and I think it will take some
time to know clearly, and with some confidence, what exactly the use cases could be and how
valuable they are. But it's important enough that you've got to study it carefully.
Anna Cross
Thank you very much, Chris. Can we have the next question, please?
Rob Noble, Deutsche Bank
Good morning. Thanks for taking my questions. Just on private credit again, could you help us
with the economics of how that business works? So what spread are you making on the business,
the risk weights? I presume it's been growing very quickly. Are you worried that if the Bank of
England, I mean regardless of how confident and low risk your particular book is, are you worried
that if the Bank of England is looking into it, it's going to deter you from further growth in that area?
And then in Kensington in the UK, I see you've doubled the book, so that makes around £4 billion
now, if I'm not mistaken. Do you have any desire to go into any other areas of specialised lending
in the UK? Thanks.
C.S. Venkatakrishnan
Right. Let me take the first one, Rob, and then Anna will cover Kensington. So, we have a disclosure
slide, slide 43 in our [Q325 Results Presentation] on private credit. What I would say is that the
exposure is growing in a sort of relatively stable manner and has been for us for a while. I'm not
going to get into RWAs and spreads.

-- 6 of 23 --

Investor Relations
7
I think we've been very clear about the strong credit controls we put on this and the types of
people we work with. To reiterate, we work with the most experienced, well-regarded, top-notch,
top players in the industry. We provide financing generally against pools of loans, of credits which
they originate on a secured basis. Those portfolios are diversified.
We have limits on borrower concentration and sector concentrations. We are skewed towards
large-cap corporates. We require lower LTVs so that we can get better first-class protection, and
we've got some statistics there, and we retain revaluation rights, which means mark-to-market
rights on the portfolio and enforce the maintenance of LTVs, and collateral additions require our
individual approval. So, it's a risk management process and practice.
I think it's important that regulators examine all aspects of the financial system. We welcome the
review by the Bank of England, and as I said, that we've got strong risk management practices. So,
we're comfortable and confident in that.
Anna Cross
Thanks, Venkat. Rob, on your question on Kensington, the balances are around £4 billion in
Kensington. Just to sort of highlight how we think about this business, I mean, it's no diferent
actually in risk management terms, to the way Venkat's just described private credit or indeed any
kind of credit.
So, we're very focused on the choice of customers, so Kensington has 30 years of experience of
really focused client and product level afordability assessments. And then once the balances are
on our balance sheet then we do manage them actively and that was one of the capabilities that
we drew from Kensington.
So, you might have noticed that in Q3, we actually did a Stage 3 securitisation from there. So, it is
quite a sophisticated risk capability, and it is contributing not only to the breadth of mortgage
offering but also to the blended margin. But thank you for the question. Next question, please.
Nicolas Payen, Kepler Cheuvreux
Good morning, thanks for taking my question. I have two please. The first one would be on your
UK RWA deployment. I think you have deployed the circa £1 billion of RWA during Q3 and it seems
to me that the run rate was actually closer to £2 billion per quarter. So especially in the context
where you had a good lending performance in Q3. So, just wanted to discuss how we should think
about it and whether or not we should have a catch-up in UK RWA deployment a bit later.

-- 7 of 23 --

Investor Relations
8
And then the second one is just to follow-up on the mortgage headwinds coming from the
maturity of the mortgage, on the return during COVID. So, what kind of headwinds are you
expecting and for how long should we expect this? Thank you very much.
Anna Cross
Thank you very much. So, we've got a £30 billion RWA target, we deployed £18 billion so far, £11
million of that is organic. It's interesting because when we set out these targets, the RWA growth
in the UK is really a shorthand for our desire to lend into the UK.
And actually what you find is that in some quarters, RWAs grow faster than lending and that's what
we saw earlier in the year and actually in this quarter lending grew faster than RWAs. It's actually
the lending that we're really focused on internally, it's the lending, not the RWAs that we generate
income from.
And we're really pleased with the progress. It's our highest quarter of net lending in mortgages
since 2021 and we've now got four consecutive quarters of lending in our corporate book. So,
we're happy with the progress, nothing really to call out it's just timing diferences between RWAs
and loans.
In terms of mortgage headwinds and look our churn efects on our book have been broadly stable,
neutral for some time, all we're calling out here is there will be a period of pressure. Actually,
overall, we expect the product margin impact on BUK as a whole, taking all products into account
will be broadly neutral into Q4. So, expect that number to be broadly zero in the NIM walk. But it's
really towards the end of 2020 and the first quarter of 2021, there was a Stamp Duty holiday in the
UK, and a lot of business was written. That's going to mature. It will compress margins a little as
that business flips over onto front book.
I'm not going to call out a particular spread that will be diferent by lender and diferent by product.
But it's just something for you to consider. And as I say, we've already taken it into account in the
guidance that we've given you. But thank you for the questions. Next question, please.
Jonathan Pierce, Jeferies
Hello, there. I've got two questions, actually. The first is on what we're going to get for the year
with regard to these 2027-2028 targets. I'm not after the numbers, of course, unless you want to
give them to us. But the sort of detail, I'm assuming it's probably not another hundred slide
presentation like we got last February. But I'm assuming we will get RoTE targets for 2028

-- 8 of 23 --

Investor Relations
9
distribution amounts and mix, maybe even [CET1 ratio] targets, these sorts of things. So just to
give us an idea of what we should be expecting qualitatively ahead of February would be helpful.
Secondly, maybe I can try and pre-empt one little piece of that, though, which is on the structural
hedge. The weighted average life has moved out now to three and a half years. When we think
about the size of maturities coming through in 2027-2028, should we be thinking therefore, we've
been getting recently to £35 billion a year or will it hold up at £50 billion for a little longer? And
maybe I can invite you to give us the maturity yield in 2028 itself, if that's possible. Thank you.
Anna Cross
Okay. Thank you, Jonathan. I will take both of those. So, we have said that we will give you updated
targets in FY25, so in February. We've also said that Venkat and I will do that together. So, you
should hopefully read from that, that it won't be quite such a long update as it was last time. But
we will be focused on 2026, 2027 and 2028.
So, what should you expect? We were really clear at the time that greater than 12% RoTE was not
an end point. And that was true of every target that we gave you. That remains true, so you should
expect us to come back with details on how we expect to push RoTE higher, not just as a Group,
but specifically in some business areas also. There's a pattern of delivery that you should be
seeing that you should continue to expect, which is higher levels of revenue, but particularly
focused on the stability and predictability of that revenue.
Secondly, that we'll continue to push gross e�ciency savings to create capacity and costs for
investments. And thirdly, that we will continue to be very disciplined in capital. So more on the
10th of February, but that's the trailer, if you like.
In terms of the structural hedge, just back to this point around predictability. The reason that
we've extended the duration is because we see greater stability in deposits. So, it's a response to
that. What that will naturally do is slightly lower the level of maturities as you go out a little bit
further. We haven't yet given a maturing yield for 2028. We will do that in February.
We have given you 2027 [maturing yield]. That is 2.1%. So, you've got 1.5% in 2025 and 2026, then
2.1% in 2027. And really what's happening here is because we are extending that, clearly, we have
a mix of maturities within that maturing yield or a mix of tenors within that maturing yield. And
there is a portion of seven year in there that is really holding down that maturing yield as we go a
little bit further out. So hopefully that gives you some things to work on and we'll come back to it
in February. Thanks, Jonathan. Next question, please.

-- 9 of 23 --

Investor Relations
10
Amit Goel, Mediobanca
Hi, thank you for taking my questions. So, two follow-up questions, actually. One, just coming
back in terms of the strategy update or new targets for 2028 that we get with full year [results].
I'm just kind of curious how you're going through that process and are you thinking about kind of
things like revising capital allocation to the businesses, things like that? Or is it more about
e�ciency and driving more out of the business with the kind of path already set?
And then secondly, just on the USCB, I think you remarked earlier that for the next couple of
quarters, so Q4, Q1, you'd anticipate a kind of a flattish NIM on what we've just seen, the 11.5%.
I'm just kind of curious, given the factors that you outlined before in terms of improvement, why
that would be flat and why that wouldn't continue to show a bit of growth in the coming periods.
Thank you.
C.S. Venkatakrishnan
Hey Amit, thanks. Good questions. I'll take the first one and Anna will take second one. So you
should see the way we're thinking about the strategy is actually what you said in the second half
of your statement, which is we're happy with the business footprint, intensification of the aspects
which Anna just referred to, top line revenue, e�ciency, depth and breadth of product reach. And
so basically getting more out of each of the businesses and getting more out of the collective. So,
see a continuation and intensification of what we've done.
Anna Cross
And Amit, on your second question, I mean, I wouldn't really add anything. There is a degree of
seasonality to the business. I mean, NIM, we do see as many of those efects, having flowed
through largely already. Typically, we see slightly lower levels of retail funding as we go into the full
year, just because balance has grown. We tend to use a bit more of the broker deposits. So that
does have a little bit of an impact on NIM.
But nothing really to call out. Just assume it's broadly flat, really, over the next couple of quarters.
And as I say, it is going to pop up again from Q2 onwards. But we'll tell you a little bit more about
that.
Okay. Thank you for that, Amit. Next question, please.

-- 10 of 23 --

Investor Relations
11
Perlie Mong, Bank of America
Good morning. Just a couple of questions. First on distribution. So, I think it's very welcome to
see a buyback this quarter and moving to quarterly distributions. Can you just tell us how you
thought about it? Why did you decide to go to quarterly cadence? And in terms of going forward,
is there a sort of monthly rolling number that you are thinking about? And within the wider
distribution context, now that [your shares are trading closer to 1x] price to book, are you thinking
about maybe [doing a diferent mix of distributions, including more dividends?]. So that's number
one.
Number two is on cost. You highlighted that you've achieved your e�ciency savings one quarter
earlier than expected. But also, for next quarter, you would expect to run towards the top end of
the £200 to £300m SCAs, if you like. So is that something that you would expect to run at that
level in 2026? And as part of the strategy update, I think last time we did it, I think there was maybe
£900 million or £1 billion SCAs up front as well. Is that something that you are thinking about as
well?
Anna Cross
Thanks, Perlie. Let me take both of those. So the buyback decision, really what that reflects is our
confidence in the consistency of generation of capital, and it's just a clear articulation of the
capital priorities that we gave you at the outset of the plan, which were number one, you should
expect us to be well capitalised as a regulatory matter. Number two, returning capital to
shareholders, and number three, investing in the businesses. So, as we reflected over the last few
quarters, we've seen the strength and quality and resilience of that capital generation, this is
something that we've been thinking about.
So, what we've done is we've accelerated a portion that we would otherwise have paid at the full
year, and that's really our desire to put it in the hands of shareholders. So, nothing more significant
than that. In terms of the go forward plan, in terms of balance, cadence, et cetera, we will cover
that with you in February when we give you those target updates.
In terms of costs. So, our primary objective here is to continue to drive e�ciencies. That's what
we're doing, and our structural cost actions play a really key role in driving that forward. But
there's no real change here at all, and in fact, given the delivery of [our FY25 gross e�ciencies
target] a quarter early, and given we've got such momentum in our NII, had it not been for motor
finance, I would have been expecting today to upgrade the cost to income ratio to around 60%.

-- 11 of 23 --

Investor Relations
12
As it is, given that progress, we've been able to absorb motor finance and reiterate our 61%
guidance to you.
I still expect next year to be in the high-50s. Typically, in any year, we spend between £200 million
and £300 million [on SCAs]. That's what we're guiding you to this year. We're just calling out it
might be towards the top end of that, but again, that is all encapsulated within the guidance that
we've given you of circa 61% for this year. There's no real change to anything that we are saying
in terms of costs. But thank you for the question. Perhaps we could go to the next question,
please.
Alvaro Serrano, Morgan Stanley
Hi, thanks for taking my question. I guess there are two follow-ups. I apologise for another one on
private credit. As you look at what went wrong in Tricolor and you've reviewed the rest of the book,
are you satisfied that the collateral integrity is there, and can you reassure us? And when we think
about this business going forward, obviously Financing has been a source of growth for a while. I
think, Venkat, you may have alluded to this, but should we expect that growth to slow down from
that 20% run rate that you've been doing for a while?
And the second question, I guess it's also a follow-up on USCB. To get to that 15% RoTE, Anna,
that you've often quoted, do you think you've got the right scale? I'm thinking obviously in a post-
American Airlines world. Or would you expect more Joint Ventures, more contract wins, and
how's the pipeline looking on any further wins? I haven't seen sort of chunky ones. Obviously,
you've had General Motors, but that's been announced a while ago. So maybe some comments
on the pipeline on wins on there. Thank you.
C.S. Venkatakrishnan
Hey, thanks, Alvaro. Let me start with the first one. So, about the review that we took, it's along
the three dimensions which I said to you. One is the company is being �nancially stretched. The
second part is strength of financial controls in the company and independence of financial
controls.
I also want to be very clear, there's sort of broad financing, there's private credit. The slide we've
given you is on private credit. And on our pattern of growth, it's been relatively stable, growing a
little bit, growing slowly. And I would always say on these things, on lending, it is a case-by-case
decision.

-- 12 of 23 --

Investor Relations
13
We will look at loans and we will decide. We tend not to grow these books that aggressively and as
you also know, I think that we tend to employ over the cycle, risk transfer transactions, and we've
been doing so for a decade. So that's been our broad approach to both risk management, to credit
risk management, and to the overall portfolio.
And then the second part of your question on private credit was basically for Anna, so I'll pass it
over.
Anna Cross
Yes, sure. So, your question references the mid-teens sort of aspiration we have for this business.
I mean, a large part of that is in our hands now, and you can see the progress that we're making
around e�ciency. We targeted mid-40s cost to income ratio. We're already at 43%, so expect us
to push on. You can see the progress in the NIM. So, all of those things are within our control.
We do want to grow the book. We will never do so at the expense of RoTE, and we have seen
opportunities to do it organically, as I said, and inorganically. So, for example, through General
Motors. As you can imagine, we look at portfolios all the time, and we assess those as to whether
or not they are RoTE generative, both for USCB and in the context of the Group.
The nature of this business is that it is always a balance of those two things. It's always a balance
of leaning into the partners that we've already got and expanding those, which we've got good
experience of, but also acquiring new capabilities and partners as we go.
So, I'll hand to Venkat.
C.S. Venkatakrishnan
Yes, sorry. There was one part I didn't answer, Alvaro. You asked me about the review that we did
and what we found. So, we reviewed it in the way I just said, looking at companies and looking at
controls. We're satisfied with what we've seen so far in our portfolio, what we've seen in the review
we've conducted. Obviously, you're going to have to remain vigilant, which we would have done
anyway, but we'll be vigilant going forward.
Anna Cross
Thank you Alvaro. Can we have the next question please?

-- 13 of 23 --

Investor Relations
14
Chris Hallam, Goldman Sachs
Hi, good morning. Thank you for taking my questions. A couple of follow-ups. Venkat, back on
NBFI, sorry, Venkat, you mentioned the importance of initial qualification and continuous
monitoring. And I guess in light of recent events that review that you're running through in that
book and just triple checking everything. How far through that review are you or have you fully
completed that review? Maybe I missed that in your earlier comments. Sorry if I did.
And then second on the Investment Bank, and it's a bit of a follow-up to Jason's question earlier
in the call, I guess this is a pretty di�cult regulatory backdrop against which to set a three-year
plan. You mentioned that we're yet to see what the US will do and the degree of alignment the UK
will settle at. So, should we think that the 2028 Investment Bank business plan is going to be sort
of caveated that it's regulatory dependent? Or do you think that the balance of outcomes on
deregulation and your earlier point on capital versus balance sheet headroom means that you
have and will sustain a plan for all seasons?
C.S. Venkatakrishnan
Yes, thanks Chris, I'll let Anna take the second question.
On the first one, the review is completed. As I said, I'm satisfied with what we saw, but we're going
to have to continue to be vigilant and that's always been the case.
Anna Cross
And Chris, just on your second question, I mean you're right, there is a degree of regulatory
uncertainty out there and clearly what we would want to have is consistency of regulation both in
its approach and its implementation date across all three jurisdictions, so Europe, UK and US. So
that is di�cult from a timing perspective in terms of planning.
But more holistically than that, the plans and the strategy that we have for the Investment Bank,
Venkat's referred to it before as running our own race and we remain extremely focused on doing
that, obviously mindful of the competitive environment also.
But our objective here is and will remain to drive higher returns in the Investment Bank, more
consistent returns and that's really about focusing on the stability of income, both stable sources
of income like the International Corporate Bank, like Financing, but also stabilising the
Intermediation and Fees parts of the business. There's a really important piece here around costs

-- 14 of 23 --

Investor Relations
15
and e�ciency and technology-led e�ciency. So what you've seen over the last few quarters,
we've had six quarters of consecutive positive jaws in this business.
And then the third piece is just this continued driving capital e�ciency. We think we've got ways
to go, you've seen again six consecutive quarters of year-over-year improvement, but there's
more there for us to do. So, I think it's really important that we focus on the things that we can
control and then navigate the regulatory environment as it emerges, and we are well used to doing
that. We've seen divergences before, we continue to see them and we'll deal with it when we have
the facts in front of us.
Thank you for the questions. Next question please.
Andy Coombs, Citigroup
Good morning. Two questions please. Firstly, if I could just follow-up on the Investment Bank,
obviously you had a very strong first half of the year. Q3 has perhaps slightly lagged the growth
seen at the US peers. Can you explain how much you think that's just a mix efect, is it a mix efect
by business segment, by region, across Equities and across primary. Or are there any gaps that
you're still looking to infill there?
And then the second question, broader question on the UK, you've obviously seen strong
mortgage and corporate loan growth in Q3, but can you perhaps touch upon customer behavior
and activity going into the November budget? Thank you.
C.S. Venkatakrishnan
Hey Andy, thanks. Let me begin with the Investment Bank and then I will pass over to Anna on the
UK.
As I've told you, I take a long view of this. We are running our own race, we set out targets, we put
in an RWA target for the Investment Bank, which was to keep it flat, and we've kept it flat. We also
instituted RWA discipline, which Anna just spoke about. And then we had both revenue targets,
cost e�ciency targets, and overall return targets, profitability targets, all of which we've been
meeting.

-- 15 of 23 --

Investor Relations
16
We also put in within that certain areas of focus within Markets and Banking. In Markets, it was
European rates, it was Securitised Products, it was Equities, particularly Equity Derivatives. In
Banking, it was certain sectors, healthcare and tech, and then it was M&A and ECM.
Now, over this long period, we have shown strong progress in all these dimensions. Even if you
look at something like Equity Derivatives, we've been growing a couple of percent over this year,
less than what the US peers have this quarter. Quarter-to-quarter, there will be variations. Some
of that variation is about the amount of capital and balance sheet some of the competitors
allocate overtime. Some of that variation is geographical concentration. So, Asia has been strong.
We've always been very clear that we have a solid Asian presence, but it's not as deep and broad
as others have. There are times when commodities plays a role, there's times when credit plays a
role, and that's generally good for us.
So, I would view what you've seen in this quarter's results as that kind of normal quarter-on-
quarter variation. I don't think when I look at the plans of the Investment Bank, what we've had,
what we intend to do, that there are sort of gaps or holes we need to fill. I think we continue to
build on technology, continue to build on product sophistication, continue to build on client reach,
and we will show the returns that we've set out to, and we've displayed over the last seven
quarters.
Anna Cross
Thanks, Venkat. Andy, here's how I think about the UK landscape. So, I think about it first in how
are consumers spending? What does the demand for credit look like? And then thirdly, how is that
credit performing? And if you look through these lenses, then you get a pretty good view.
So, I mean, UK consumer behavior is slightly cautious, but we continue to see signs of
improvement. So, credit spend is higher than debit spend. We've seen a slight increase in non-
essential spending, and confidence metrics have grown slightly. So, so far so good.
And we also see that flowing into, for example, the demand for credit, and you can see that in
terms of our UK momentum. The demand for mortgage credit is good, and as I said that's not just
refinancing. So, in a very cautious environment, you see less house purchase.
But what we see is house purchase growth, first-time buyer growth, and also refinancing demand.
There's good demand from cards, as you can see, and actually the thing we talk about less is
demand from corporates, and you can see really good lending in our corporate book. That is
coming broadly half and half from existing clients and new clients.

-- 16 of 23 --

Investor Relations
17
We've originated more than 400 new clients this year. That's on top of the 550 that we did last year,
and our lending market share is up 70 bps. So, we don't see a lack of demand for credit at a macro
level. So, if we're looking for points that were slightly more hesitant, we would say we see a little
bit of hesitancy in mid-corporate, but generally speaking, good demand for credit.
And then finally, credit performance is good. We see that in mortgages. We see it in cards. I mean,
UK cards delinquencies are extremely low, and I would say across all of the portfolios are low and
stable and exactly as we would have expected them to be. And the same is true of corporates.
There are no significant single names in our corporate book. So, the UK landscape remains pretty
robust.
Thank you Andy for your questions. Can we have the next question, please?
Ben Toms, RBC
Good morning, both. Thank you for taking my questions. The first is in relation to a European bank
peer whose shares sufered this week in relation to losing a US litigation case that was
underpinned by the fact that the bank provided finance to a sanctioned nation.
I think that Barclays settled with the US regulations in 2010 in respect to providing finance to a
sanctioned nation. Can you provide any comfort for us why we shouldn't add this to a potential
litigation risk for Barclays in the future?
And then secondly, in Private Banking and Wealth Management, the AUM and AUS grew pretty
quickly in the quarter. To what extent do you expect this organic growth trend to continue over
the next 12 months? Thank you.
Anna Cross
In terms of the first point, there's nothing of which I would call out, Ben. We can follow up with you
with a bit more detail about the historic cases, but nothing I would call out.
On your second point, we continue to make good progress with the Private Bank, another £0.7
billion of net new [AUM] in the quarter, so we're pleased with its progress and obviously its RoTE
remains above its target level, which was greater than 25%, so pretty robust.
Obviously, the opportunity for that business, we believe, really comes in the future as we start to
access the sort of Mass A�uent and Wealth Markets, so probably more to come on that. I
wouldn't call out anything specific now, but again, thank you for the questions.

-- 17 of 23 --

Investor Relations
18
Perhaps we could have the next question, which I believe is our last question.
Ed Firth, KBW
Thanks very much. Good morning, everybody. I just had a question on your 2026 targets, actually,
because if I look across the piece, I mean, you're pretty much nailing every one and some by some
margin, but I guess the one that stands out is the Investment Bank RWAs, which I can see you've
reiterated today at 50%, which is still quite a long way from where we are today.
And I'm just thinking that in terms of the returns, they are significantly below the other divisions.
And I would hazard that the cost of equity is higher as well, and I guess that's probably the division
which is the reason for you trading where you do. So, I do think that 50% is quite an important
target, particularly in terms of a statement of intent and where we see it going from there. But I
don't really see how you're going to get there.
And so can you give us sort of some flavor are we talking about a big reduction in Investment Bank
RWAs? Is it some sort of risk transfer you're going to do? Or are we looking at much bigger growth
somewhere that I'm not thinking about? Because you're talking about more than a 10% swing
there. Thanks very much.
Anna Cross
Okay, Ed, why don’t I start and then I'll hand to Venkat. So just in terms of the 50%, remember,
when we wrote that, we were in a very diferent environment in terms of regulatory timing. So,
there are two things that are under our control and one that isn't. The first is holding the
Investment Bank RWAs flat. We've actually done that for more than three and a half years now. It's
not just part of this strategy, it was there before.
Secondly, continuing through in the UK and you can see the progress. The thing that I can't control
is the implementation date of the IRB model or indeed, some of the Basel implementation efects.
But the strategic intent that sits underneath that 50% remains the same, Ed, but there's
regulatory timing that I can't control.
As to your point on returns, I mean, we were really clear that the returns of the Investment Bank
were not where they needed to be, but you can see that we're making progress. Just to call it out,
it's 12.9% year-to-date, much more in line with the Group versus 10.1% last year. So, we are
making good progress, but I'll hand to Venkat for more comments.

-- 18 of 23 --

Investor Relations
19
C.S. Venkatakrishnan
Yes, look, I'll say exactly that. We were very, very clear at the start of our strategy that we were
going to hold the Investment Bank RWAs flat. And the reasoning behind that was we felt and we
feel we've got a very strong, capable full Investment Bank, and that at those levels of RWA, with
greater RWA e�ciency, which we’ve demonstrated, can be very competitive. And we've shown
our competitiveness over the long time, over this period.
What we said also was that the percentage is an outcome, as Anna just described, which is based
on not just holding it flat, but growing in the UK, and then assumptions about capital calculations
for the rest of our book, particularly US Cards. The first two we control, holding the Investment
Bank RWAs flat, and then what we've been doing in the UK, where we've been showing the growth,
which we said we would. The third part we cannot control, and that afects the percentage. And if
you go beyond that. The flat is exactly the important point.
And as Anna said, on RoTE, it's again been behaving exactly the way we would want, it's a returns
focused business. And it is approaching, and in some instances, if you look at the time periods of
the past, the Group average. So exactly what was outlined, exactly what has been delivered, the
promise is kept. Thank you very much, everybody.
Anna Cross
Thank you. Thank you, everybody. Thank you, Ed, for that question. We will see you on the road
from tomorrow, and we are looking forward to an analyst lunch as opposed to an analyst breakfast
next Tuesday. So, I hope to see you all soon, and thank you for your continued interest in Barclays.
Thank you.
C.S. Venkatakrishnan
Thank you.

-- 19 of 23 --

Investor Relations
20
Important Notice
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information,
statements and opinions contained in this presentation do not constitute a public ofer under any
applicable legislation, an ofer to sell or solicitation of any ofer to buy any securities or �nancial
instruments, or any advice or recommendation with respect to such securities or other �nancial
instruments.
Information relating to:
• 	regulatory capital, leverage, liquidity, resolution and related regimes is based on Barclays'
interpretation of applicable rules and regulations as in force and implemented in the UK
as at the reporting date, including, but not limited to: CRR; the PRA Rulebook; and any
applicable delegated acts, implementing acts or technical standards; in each case as
amended and, where applicable, as such rules and regulations form part of domestic law
by virtue of the European Union (Withdrawal) Act 2018. All such regulatory requirements
are subject to change and disclosures made by the Group will be subject to any resulting
changes. The Pillar 2A requirement is also subject to at least annual review;
• 	MREL is based on Barclays' understanding of the Bank of England’s Statement of Policy on
"The Bank of England's approach to setting a minimum requirement for own funds and
eligible liabilities (MREL)" published in December 2021, and its MREL requirements
communicated to Barclays by the Bank of England. MREL requirements remain subject to
change, as determined by the Bank of England, taking into account a number of factors as
described in the policy, along with international developments;
• 	future regulatory capital, leverage, liquidity, funding and/or MREL, including forward-
looking illustrations, are provided for illustrative purposes only and are not forecasts of
Barclays’ results of operations or capital position or otherwise. Illustrations regarding the
capital �ight path, end-state capital evolution and expectations and MREL build are based
on certain assumptions applicable at the date of publication only which cannot be assured
and are subject to change.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance measures included in this
presentation provide valuable information to the readers of the �nancial statements as they
enable the reader to identify a more consistent basis for comparing the businesses’ performance
between �nancial periods and provide more detail concerning the elements of performance
which the managers of these businesses are most directly able to in�uence or are relevant for an

-- 20 of 23 --

Investor Relations
21
assessment of the Group. They also re�ect an important aspect of the way in which operating
targets are de�ned and performance is monitored by Barclays’ management. However, any non-
IFRS performance measures in this presentation are not a substitute for IFRS measures and
readers should consider the IFRS measures as well. Refer to the appendix of the Barclays PLC
Results Announcement for each of the periods ended 30 June 2019, 30 June 2021, 30 June 2023,
30 June 2024, 30 September 2024, 31 December 2024 and 31 March 2025 and the Group
Reporting Changes 2023 Results Resegmentation Document, respectively, which are available at
Barclays.com, for further information and calculations of non-IFRS performance measures
included throughout this presentation, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E
of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act
of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-
looking statement is a guarantee of future performance and that actual results or other �nancial
condition or performance measures could difer materially from those contained in the forward-
looking statements. Forward-looking statements can be identi�ed by the fact that they do not
relate only to historical or current facts. Forward-looking statements sometimes use words such
as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’,
‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements
can be made in writing but also may be made verbally by directors, o�cers and employees of the
Group (including during management presentations) in connection with this document.
Examples of forward-looking statements include, among others, statements or guidance
regarding or relating to the Group’s future �nancial position, business strategy, income levels,
costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory
ratios, capital distributions (including policy on dividends and share buybacks), return on tangible
equity, projected levels of growth in banking and �nancial markets, industry trends, any
commitments 	and 	targets 	(including 	environmental, 	social 	and 	governance 	(“ESG”)
commitments and targets), plans and objectives for future operations, International Financial
Reporting Standards (“IFRS”) and other statements that are not historical or current facts. By
their nature, forward-looking statements involve risk and uncertainty because they relate to
future events and circumstances. Forward-looking statements speak only as at the date on which
they are made. Forward-looking statements may be afected by a number of factors, including,
without limitation: changes in legislation, regulations, governmental and regulatory policies,
expectations and actions, voluntary codes of practices and the interpretation thereof, changes

-- 21 of 23 --

Investor Relations
22
in IFRS and other accounting standards, including practices with regard to the interpretation and
application thereof and emerging and developing sustainability reporting standards (including
emissions accounting methodologies); changes in tax laws and practice; the outcome of current
and future legal proceedings and regulatory investigations; the Group’s ability along with
governments and other stakeholders to measure, manage and mitigate the impacts of climate
change efectively or navigate inconsistencies and con�icts in the manner in which climate policy
is implemented in the regions where the Group operates, including as a result of the adoption of
anti-ESG rules and regulations, or other forms of governmental and regulatory action against
ESG policies; environmental, social and geopolitical risks and incidents and similar events beyond
the Group’s control; �nancial crime; the impact of competition in the banking and �nancial
services industry; capital, liquidity, leverage and other regulatory rules and requirements
applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and
business conditions, including in�ation; volatility in credit and capital markets; market related
risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest
rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within
the Group or any securities issued by it; changes in counterparty risk; changes in consumer
behaviour; changes in trade policy, including the imposition of tarifs or other protectionist
measures; the direct and indirect consequences of the con�icts in Ukraine and the Middle East on
European and global macroeconomic conditions, political stability and �nancial markets; changes
in US legislation and policy following the US elections in 2024; developments in the UK’s
relationship with the European Union; the risk of cyberattacks, information or security breaches,
technology failures or operational disruptions and any subsequent impact on the Group’s
reputation, business or operations; the Group’s ability to access funding; and the success of
acquisitions (including the acquisition of Tesco Bank completed in November 2024), disposals,
joint ventures and other strategic transactions. A number of these factors are beyond the Group’s
control. As a result, the Group’s actual �nancial position, results, �nancial and non-�nancial
metrics or performance measures or its ability to meet commitments and targets may difer
materially from the statements or guidance set forth in the Group’s forward-looking statements.
In setting its targets and outlook for the period 2024-2026, Barclays has made certain
assumptions about the macroeconomic environment, including, without limitation, in�ation,
interest and unemployment rates, the diferent markets and competitive conditions in which
Barclays operates, and its ability to grow certain businesses and achieve costs savings and other
structural actions. Additional risks and factors which may impact the Group’s future �nancial
condition and performance are identi�ed in Barclays PLC’s �lings with the US Securities and
Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on

-- 22 of 23 --

Investor Relations
23
Form 20-F for the �nancial year ended 31 December 2024), which are available on the SEC’s
website at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant
jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing
information, we undertake no obligation to update publicly or revise any forward-looking
statements, whether as a result of new information, future events or otherwise

-- 23 of 23 --